title: Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.
authors.affiliation: Division of Haematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: Satheesh
authors.initials: S
authors.lastname: Chonat
authors.affiliation: Division of Haematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: Shanmuganathan
authors.initials: S
authors.lastname: Chandrakasan
authors.affiliation: Division of Haematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: Karen Ann
authors.initials: KA
authors.lastname: Kalinyak
authors.affiliation: Division of Haematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: David
authors.initials: D
authors.lastname: Ingala
authors.affiliation: Division of Haematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: Ralph
authors.initials: R
authors.lastname: Gruppo
authors.affiliation: Division of Haematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
authors.forename: Theodosia A
authors.initials: TA
authors.lastname: Kalfa
mesh_terms: D000755:Anemia, Sickle Cell / Q000150:complications*; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome / Q000188:drug therapy* / Q000473:pathology; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab
keywords: atypical haemolytic uraemic syndrome; complement mutations; eculizumab; sickle cell disease; thrombotic microangiopathy